v3.20.4
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Jun. 30, 2020
Current assets:    
Cash $ 117,538 $ 197,622
Accounts receivable – net 41,290 61,013
Inventories 166,041 275,605
Other current assets 212,226 398,085
Total current assets 537,095 932,325
Total assets 537,095 932,325
Current liabilities:    
Accounts payable 1,140,205 1,286,149
Accrued expense-related party 9,974 9,974
Accrued expense 56,923
Accrued interest 248,492 192,625
Short term borrowings - line of credit 1,692 3,897
Convertible notes payable - net of discount 2,551,104 2,330,189
Fair value of derivative liabilities 1,416,045 1,590,638
Total current liabilities 5,424,435 5,413,472
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of December 31, 2020 and 1,000 outstanding as of June 30, 2020, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 68,886,863 issued and outstanding as of December 31, 2020 and 61,796,680 outstanding as of June 30, 2020, respectively) 68,887 61,797
Additional paid in capital 14,217,423 13,088,177
Accumulated deficit (19,173,651) (17,631,122)
Total stockholders' deficit (4,887,339) (4,481,147)
Total Liabilities and Stockholders' Deficit $ 537,095 $ 932,325

Source